The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
An anti-infective peptide that selectively modulates the innate immune response
Abstract
We show that an innate defense-regulator peptide (IDR-1) was protective in mouse models of infection with important Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus and Salmonella enterica serovar Typhimurium. When given from 48 h before to 6 h after infection, the peptide was effective by both local and systemic administration. Because protection by IDR-1 was prevented by in vivo depletion of monocytes and macrophages, but not neutrophils or B- and T-lymphocytes, we conclude that monocytes and macrophages are key effector cells. IDR-1 was not directly antimicrobial: gene and protein expression analysis in human and mouse monocytes and macrophages indicated that IDR-1, acting through mitogen-activated protein kinase and other signaling pathways, enhanced the levels of monocyte chemokines while reducing pro-inflammatory cytokine responses. To our knowledge, an innate defense regulator that counters infection by selective modulation of innate immunity without obvious toxicities has not been reported previously.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The reaction of neutrophils and macrophages during infection triggers the production of innate defence regulatory peptide 1 IDR1, with similar activity to defensins or cathelicidins [223].”
From Superoxide Anion Chemistry—Its Role at the Core of the Innate Immunity (2023) · cites this paper as [223]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Alarmins: chemotactic activators of immune responses
Oppenheim, J. J., & Yang, D. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.06.002 · Cited by 780
NLRs join TLRs as innate sensors of pathogens
Martinon, F., & Tschopp, J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.004 · Cited by 673
Toll-Like Receptors: Linking Innate and Adaptive Immunity
Pasare, C., & Medzhitov, R. M. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-24180-9_2 · Cited by 666
How Toll-like receptors signal: what we know and what we don’t know
O'Neill, L. A. J. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.012 · Cited by 614
Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G., Pistolic, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2455 · Cited by 562
Self-citationInnate immune responses to infection
Tosi, M. F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.036 · Cited by 387
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K. C. L., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 382
Self-citationCavaillon, J., Adib‐Conquy, M., Fitting, C., Adrie, C., & Payen, D. M. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015935 · Cited by 336
Research works printed but not linked: 1
- National Research Council Treating Infectious Diseases in a Microbial World: Report of Two Workshops. Washington, D.C.: The National Academies Press, (2005).
Cited by
Sorted by citations
Items 201–300 of 401
Uppu, D. S. S. M., Ghosh, C., & Haldar, J. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.02.001 · Cited by 33
Odunitan, T. T., Oyaronbi, A. O., Adebayo, F. A., Adekoyeni, P. A., Apanisile, B. T., Oladunni, T. D., & Saibu, O. A. (2023) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2023.100034 · Cited by 32
Yang, Y., Wu, J., Li, Q., Wang, J., Mu, L., Li, H., Li, M., Xu, W., Yang, H., & Wei, L. (2022) · eLife · doi:10.7554/elife.72849 · Cited by 32
Yu, H., Lu, Y., Qiao, X., Wei, L., Fu, T., Cai, S., Wang, C., Liu, X., Zhong, S., & Wang, Y. (2015) · Scientific Reports · doi:10.1038/srep11082 · Cited by 32
The LL-37 domain: A clue to cathelicidin immunomodulatory response?
Leite, M. L., Duque, H. M., Rodrigues, G. R., da Cunha, N. B., & Franco, O. L. (2023) · Peptides · doi:10.1016/j.peptides.2023.171011 · Cited by 31
Zhao, H. Y., Tang, J., Cao, L., Jia, G., Long, D., Liu, G., Chen, X., Cai, J., & Shang, H. (2015) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2015.06.001 · Cited by 31
Proteome Exploration to Provide a Resource for the Investigation of Ganoderma lucidum
Yu, G., Yin, Y.-L., Yu, W., Liu, W., Jin, Y., Shrestha, A., Yang, Q., Ye, X.-D., & Sun, H. Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119439 · Cited by 31
Magliani, W., Conti, S., Ciociola, T., Giovati, L., Zanello, P. P., Pertinhez, T. A., Spisni, A., & Polonelli, L. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.71 · Cited by 32
Marciano, C. L., de Lima, J. V. F., Rosa, M. S. D. C., do Nascimento, R. A., Ferraz, A. D. O., da Silva, I. C., Chrysostomo-Massaro, T. N., da Rosa-Garzon, N. G., & Cabral, H. (2025) · Antibiotics · doi:10.3390/antibiotics14111115 · Cited by 32
Protein epitope mimetics as anti-infectives
Robinson, J. A. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.02.015 · Cited by 31
Huang, H.-N., Rajanbabu, V., Pan, C., Chan, Y.-L., Hui, C., Chen, J., & Wu, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.053 · Cited by 30
North, J. R., Takenaka, S., Rozek, A., Kielczewska, A., Opal, S. M., Morici, L. A., Finlay, B. B., Schaber, C. J., Straube, R., & Donini, O. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.03.032 · Cited by 29
Self-citationAmatngalim, G. D., Nijnik, A., Hiemstra, P. S., & Hancock, R. E. W. (2010) · Inflammation · doi:10.1007/s10753-010-9248-6 · Cited by 29
Self-citationFrey, M. E., D’Ippólito, S., Pepe, A., Daleo, G. R., & Guevara, M. G. (2018) · Phytochemistry · doi:10.1016/j.phytochem.2018.02.004 · Cited by 28
Zohrab, F., Askarian, S., Jalili, A., & Oskuee, R. K. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9723-8 · Cited by 28
In vitro and in vivo properties of the bovine antimicrobial peptide, Bactenecin 5
Price, R. L., Bugeon, L., Mostowy, S., Makendi, C., Wren, B. W., Williams, H. D., & Willcocks, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210508 · Cited by 29
Critical Protective Role for MCP-1 in Pneumonic Burkholderia mallei Infection
Goodyear, A., Jones, A., Troyer, R. M., Bielefeldt‐Ohmann, H., & DOW, S. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900411 · Cited by 28
Use of tilapia piscidin 3 (TP3) to protect against MRSA infection in mice with skin injuries
Huang, H.-N., Chan, Y.-L., Hui, C., Wu, J., Wu, C., & Chen, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4102 · Cited by 27
An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model
de Freitas, C. G., Lima, S. M. D. F., Freire, M. S., Cantuária, A. P. D. C., Oliveira-Júnior, N. G., dos Santos, T. S., Folha, J. D. S., Ribeiro, S. M., Dias, S. C., Rezende, T. M. B., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02518-16 · Cited by 27
Self-citationvan der Does, A. M., Bogaards, S. J. P., Jonk, L. J. C., Wulferink, M., Velders, M. P., & Nibbering, P. H. (2010) · BioMetals · doi:10.1007/s10534-010-9322-4 · Cited by 27
Yu, H., Wang, C., Feng, L., Cai, S., Liu, X., Qiao, X., Shi, N., Wang, H., & Wang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-02050-2 · Cited by 27
Eriksson, O. S., Geörg, M., Sjölinder, H., Sillard, R., Lindberg, S., Langel, Ü., & Jonsson, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00624-13 · Cited by 26
Chen, Y., Li, C., Zhu, J., Xie, W., Hu, X., Song, L., Zi, J., & Yu, R. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.11.082 · Cited by 26
Targeting the host–pathogen interface for treatment of Staphylococcus aureus infection
Park, B., & Liu, G. Y. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0297-1 · Cited by 25
Addressing Antibiotic Failure—Beyond Genetically Encoded Antimicrobial Resistance
Haney, E. F., & Hancock, R. E. W. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.892975 · Cited by 25
Self-citationAligning Antimicrobial Drug Discovery with Complex and Redundant Host-Pathogen Interactions
Lebeis, S. L., & Kalman, D. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.01.008 · Cited by 24
Domalaon, R., Yang, X., O’Neil, J. D., Zhanel, G. G., Mookherjee, N., & Schweizer, F. (2014) · Amino Acids · doi:10.1007/s00726-014-1806-z · Cited by 23
Self-citationGao, J., Zhang, M., Zhang, F., Wang, Y., Ouyang, J., Luo, X., Yang, H., Zhang, D., Chen, Y., Yu, H., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00255 · Cited by 23
Host defense peptides as immunomodulators: The other side of the coin
Martell-Huguet, E. M., González-García, M., Ständker, L., & Otero‐González, A. J. (2021) · Peptides · doi:10.1016/j.peptides.2021.170644 · Cited by 23
Ali, W., Elsahn, A. F., Ting, D. S. J., Dua, H. S., & Mohammed, I. (2022) · Antibiotics · doi:10.3390/antibiotics11040475 · Cited by 23
Host Defense Peptides in the Oral Cavity
DeVine, D., & Cosseau, C. (2008) · Advances in applied microbiology · doi:10.1016/s0065-2164(07)00008-1 · Cited by 25
Haney, E. F., Barbosa, S. C., Baquir, B., & Hancock, R. E. W. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01344 · Cited by 22
Self-citationUmadevi, P., Soumya, M., George, J. K., & Anandaraj, M. (2018) · Physiology and Molecular Biology of Plants · doi:10.1007/s12298-018-0524-5 · Cited by 22
Li, J., Chen, J., Yang, G., & Tao, L. (2021) · Peptides · doi:10.1016/j.peptides.2021.170533 · Cited by 22
Yanashima, K., Chieosilapatham, P., Yoshimoto, E., Okumura, K., Ogawa, H., & Niyonsaba, F. (2017) · Immunologic Research · doi:10.1007/s12026-017-8932-0 · Cited by 22
Kudrimoti, M. R., Curtis, A. E., Azawi, S., Worden, F. P., Katz, S. R., Adkins, D. R., Bonomi, M. R., Scott, Z., Elder, J., Sonis, S. T., et al. (2017) · Biotechnology Reports · doi:10.1016/j.btre.2017.05.002 · Cited by 21
Self-citationKorhonen, E., Piippo, N., Hytti, M., Hyttinen, J. M. T., Kaarniranta, K., & Kauppinen, A. (2019) · Cytokine · doi:10.1016/j.cyto.2018.12.015 · Cited by 21
Lee, H. Y., & Bae, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.046 · Cited by 21
Jang, S. A., Sung, B. H., Cho, J. H., & Kim, S. C. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02753-08 · Cited by 21
Molecular characterization of a novel ovodefensin gene in chickens
Yu, L., Xiao, Y., Li, J., Ran, J., Yin, L., Liu, Y., & Zhang, L. (2018) · Gene · doi:10.1016/j.gene.2018.08.029 · Cited by 20
Actin Enables the Antimicrobial Action of LL-37 Peptide in the Presence of Microbial Proteases
Sol, A., Skvirsky, Y., Nashef, R., Zelentsova, K., Burstyn‐Cohen, T., Blotnick, E., Mühlrád, A., & Bachrach, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.579672 · Cited by 20
Zucca, M., Scutera, S., & Savoia, D. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711796575498 · Cited by 20
Kanazawa, K., Okumura, K., Ogawa, H., & Niyonsaba, F. (2015) · Immunologic Research · doi:10.1007/s12026-015-8759-5 · Cited by 20
Wuerth, K. C., Lee, A. H., Falsafi, R., Gill, E. E., & Hancock, R. E. W. (2018) · Infection and Immunity · doi:10.1128/iai.00661-18 · Cited by 20
Self-citationYe, W.-H., Yeghiasarian, L., Cutler, C. W., Bergeron, B. E., Sidow, S. J., Xu, H. H. K., Niu, L., Ma, J.-Z., & Tay, F. R. (2019) · Journal of Dentistry · doi:10.1016/j.jdent.2019.103231 · Cited by 21
Efficient Flow Synthesis of Human Antimicrobial Peptides*
Albin, J. S., & Pentelute, B. L. (2020) · Australian Journal of Chemistry · doi:10.1071/ch20043 · Cited by 20
Dhiman, A., Talukdar, S., Chaubey, G. K., Dilawari, R., Modanwal, R., Chaudhary, S., Patidar, A., Boradia, V. M., Kumbhar, P., Raje, C. I., et al. (2023) · Journal of Innate Immunity · doi:10.1159/000530083 · Cited by 20
Mammalian Antimicrobial Peptides; Defensins and Cathelicidins
Dorin, J. R., McHugh, B. J., Cox, S. L., & Davidson, D. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00030-5 · Cited by 19
LL-37: An Immunomodulatory Antimicrobial Host Defence Peptide
Beaumont, P. E., Li, H., & Davidson, D. J. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0541-4_4 · Cited by 18
Brouwer, C. P. J. M. (2018) · Cohesive Journal of Microbiology & Infectious Disease · doi:10.31031/cjmi.2018.01.000512 · Cited by 18
Kogut, M. H., He, H., Genovese, K. J., & Jiang, Y. (2009) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2009.0346 · Cited by 18
Anti-infective peptide IDR-1002 augments monocyte chemotaxis towards CCR5 chemokines
Madera, L., & Hancock, R. E. W. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.038 · Cited by 17
Self-citationHan, Y.-C., Lin, C., & Chen, T. T. (2018) · BMC Genomics · doi:10.1186/s12864-018-5141-8 · Cited by 17
María, A., Barbassa, L., & de Melo, L. D. (2011) · InTech eBooks · doi:10.5772/14400 · Cited by 18
Sebők, C., Tráj, P., Mackei, M., Márton, R. A., Vörösházi, J., Kemény, Á., Neogrády, Z., & Mátis, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-41707-z · Cited by 16
Alt, J. A., Qin, X., Pulsipher, A., Orb, Q. T., Orlandi, R. R., Zhang, J., Schults, A. J., Jia, W., Presson, A. P., Prestwich, G. D., et al. (2015) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21634 · Cited by 16
Keely, S., Rawlinson, L.-A. B., Haddleton, D. M., & Brayden, D. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9501-3 · Cited by 16
Ramachandran, B., Jeyakanthan, J., & Lopes, B. S. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001233 · Cited by 16
McDermott, A. M. (2009) · CRC Press eBooks · doi:10.1201/9781420061161-c16 · Cited by 16
Kogut, M. H., Genovese, K. J., He, H., Swaggerty, C. L., & Jiang, Y. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.10.023 · Cited by 16
Rational design of innate defense regulator peptides as tumor vaccine adjuvants
Tian, Y., Hu, Q., Zhang, R., Zhou, B., Xie, D., Wang, Y., Zhang, X., & Yang, L. (2021) · npj Vaccines · doi:10.1038/s41541-021-00334-3 · Cited by 15
Amphiphilic Tobramycins with Immunomodulatory Properties
Guchhait, G., Altieri, A., Gorityala, B. K., Yang, X., Findlay, B., Zhanel, G. G., Mookherjee, N., & Schweizer, F. (2015) · Angewandte Chemie · doi:10.1002/ange.201500598 · Cited by 15
Self-citationImmunomodulation and effects on microbiota after in ovo administration of chicken cathelicidin-2
Cuperus, T., Kraaij, M. D., Zomer, A., van Dijk, A. I. J. M., & Haagsman, H. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198188 · Cited by 15
Chiou, M.-J., Chen, L.-K., Peng, K., Pan, C.-Y., Lin, T.-L., & Chen, J. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.07.012 · Cited by 15
Multiple Activities in Natural Antimicrobials
Sahl, H., & Bierbaum, G. (2008) · Microbe Magazine · doi:10.1128/microbe.3.467.1 · Cited by 15
Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
Jayathilaka, E. H. T. T., Rajapaksha, D. C., Nikapitiya, C., Lee, J., Zoysa, M. D., & Whang, I. (2022) · Pharmaceuticals · doi:10.3390/ph15080928 · Cited by 14
High‐yield, plant‐based production of an antimicrobial peptide with potent activity in a mouse model
Chaudhary, S., Ali, Z., Pantoja‐Angles, A., Abdelrahman, S., Baldelamar-Juárez, C. O., Rao, G. S., Hong, P., Hauser, C. A. E., & Mahfouz, M. M. (2024) · Plant Biotechnology Journal · doi:10.1111/pbi.14460 · Cited by 14
Ye, Z., Xu, Z., Ouyang, J., Shi, W., Li, S., Wang, X., Lu, B., Wang, K., & Wang, Y. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02039 · Cited by 14
Scicluna, B. P., van Lieshout, M. H. P., Blok, D. C., Florquin, S., & van der Poll, T. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00263 · Cited by 14
Lin, Q., Fu, Q., Chen, D., Yu, B., Luo, Y., Huang, Z., Zheng, P., Mao, X., Yu, J., Luo, J., et al. (2021) · Molecules · doi:10.3390/molecules26144242 · Cited by 14
Self-citationTherapeutic potential of highly diluted antibodies in antibiotic-resistant infection
Emelyanova, A. G., Petrova, N. V., Fremez, C., Fontanié, M., Тарасов, С. А., & Epstein, O. I. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106161 · Cited by 14
Prophylactic administration of chicken cathelicidin-2 boosts zebrafish embryonic innate immunity
Schneider, V. A. F., van Dijk, A. I. J. M., van der Sar, A. M., Kraaij, M. D., Veldhuizen, E. J. A., & Haagsman, H. P. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.02.023 · Cited by 14
Analysis of a gene family for PDF-like peptides from Arabidopsis
Omidvar, R., Vosseler, N., Abbas, A., Gutmann, B., Grünwald‐Gruber, C., Altmann, F., Siddique, S., & Bohlmann, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-98175-6 · Cited by 13
Yang, F., Yang, F., Huang, J., Yu, H., & Qiao, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137213 · Cited by 13
Findlay, B., Mookherjee, N., & Schweizer, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054280 · Cited by 13
Self-citationLee, J. C., Greenwich, J. L., Zhanel, G. G., Han, X., Cumming, A., Saward, L. L., & McLoughlin, R. M. (2010) · Infection and Immunity · doi:10.1128/iai.01364-09 · Cited by 13
Innate Immune Training of Human Macrophages by Cathelicidin Analogs
van Dijk, A. I. J. M., Anten, J., Bakker, A., Evers, N., Hoekstra, A. T., Chang, J., Scheenstra, M. R., Veldhuizen, E. J. A., Netea, M. G., Berkers, C. R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.777530 · Cited by 13
Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis
Shi, N., Cai, S., Gao, J., Qiao, X., Yang, H., Wang, Y., & Yu, H. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.11.010 · Cited by 13
Novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity
Kim, Y., Kim, N.-H., Lee, J.-W., Jang, J., Park, Y.-H., Park, S., & Jang, M.-K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.063 · Cited by 13
Recent advances in designing antimicrobial polymers with diverse uptake and killing mechanisms
Si, Z., & Chan‐Park, M. B. E. (2026) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2026.102080 · Cited by 13
He, Y., Shen, Y., Feng, X., Ruan, S., Zhao, Y., Mu, L., Wu, J., & Yang, H. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00316 · Cited by 14
Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity
Connors, J. R., Cusimano, G. M., Mege, N. J., Woloszczuk, K., Konopka, E., Bell, M. R., Joyner, D., Marcy, J., Tardif, V., Kutzler, M. A., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2267295 · Cited by 12
Safety evaluation of the antimicrobial peptide bovicin HC5 orally administered to a murine model
Paiva, A. D., Fernandes, K. M., Dias, R. S., Rocha, A. D. S., de Oliveira, L. L., Neves, C. A., de Paula, S. O., & Mantovani, H. C. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-69 · Cited by 12
Action of antimicrobial peptides and their prodrugs on model and biological membranes
Forde, É., Shafiy, G., Fitzgerald‐Hughes, D., Strömstedt, A. A., & Devocelle, M. C. (2018) · Journal of Peptide Science · doi:10.1002/psc.3086 · Cited by 12
Milk Derived Peptides with Immune Stimulating Antiviral Properties
Sun, H., & Jensse, H. (2012) · Milk Protein · doi:10.5772/50158 · Cited by 12
Potential neuroprotective strategies for perinatal infection and inflammation
Ranchhod, S. M., Gunn, K. C., Fowke, T. M., Davidson, J. O., Lear, C. A., Bai, J., Bennet, L., Mallard, C. E., Gunn, A. J., & Dean, J. M. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.006 · Cited by 11
Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A
Scruten, E., Kovacs-Nolan, J., Griebel, P. J., Latimer, L. J. P., Kindrachuk, J., Potter, A. A., Babiuk, L. A., den Hurk, S. V. D. L., & Napper, S. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.015 · Cited by 11
Qiao, X., Yang, H., Gao, J., Cai, S., Shi, N., Wang, M., Wang, Y., & Yu, H. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0100 · Cited by 11
In Vitro and In Vivo Antibiotic Capacity of Two Host Defense Peptides
Arenas, I., Ibarra-Valencia, M. A., Santana, F. L., Villegas, E., Hancock, R. E. W., & Corzo, G. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00145-20 · Cited by 11
Self-citationShin, J. R., Lim, K. J., Kim, D. J., Cho, J. H., & Kim, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058997 · Cited by 11
Mazumdar, A., & Adam, V. (2021) · Journal of Molecular and Clinical Medicine · doi:10.31083/j.jmcm.2021.01.208 · Cited by 11
Advancing antimicrobial peptides: Overcoming challenges in the era of bacterial resistance
Aunpad, R., & Thitirungreangchai, T. (2025) · Biochimie · doi:10.1016/j.biochi.2025.07.019 · Cited by 10
A Novel Anti-Infective Peptide BCCY-1 With Immunomodulatory Activities
Cai, J., Cui, X., Wang, X., You, L., Ji, C., & Cao, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713960 · Cited by 10
Podolnikova, N. P., Lishko, V. K., Roberson, R. W., Koh, Z., Derkach, D. N., Richardson, D. L., Sheller, M. R., & Ugarova, T. P. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1217103 · Cited by 10
Host Defense Peptides: Bridging Antimicrobial and Immunomodulatory Activities*
Kindrachuk, J., Nijnik, A., & Hancock, R. E. W. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00112-x · Cited by 10
Self-citationLi, X., Yu, H., Yu, H., Li, X., & Sun, S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01731-6 · Cited by 9
An Antimicrobial Peptide Modulates Epithelial Responses to Bacterial Products
Vonk, M. J., Hiemstra, P. S., & Grote, J. J. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e31816422d7 · Cited by 9
A Synthetic Cyclized Antimicrobial Peptide with Potent Effects against Drug-Resistant Skin Pathogens
White, J. K., Mohanty, S., Muhammad, T., de la Campa, M. D. A. S., Houssen, W. E., Ferraz, N., Göransson, U., & Brauner, A. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00598 · Cited by 9
Jin, Y., Wang, J., & Wang, Y. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09239-6 · Cited by 9
Yu, C., Luo, Z., Li, M., Lu, L., Li, Z., Wu, X., Fan, Y., ZHANG, H.-L., Zhou, B., WAN, Y., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4581 · Cited by 9
Metadata
- Authors
- Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., Yu, J. J., Li, Y., Donini, O., Guarna, M. M., Finlay, B. B., North, J. R., & Hancock, R. E. W.
- Affiliations
- City of Vancouver (CA)
- University of British Columbia (CA)
- Corresponding author
- Hancock, Robert E W
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2007-03-25
- Volume
- 25
- Issue
- 4
- Pages
- 465-472
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2040733257
- Cited by
- 403
- References
- 31
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 19 · 2023: 15 · 2022: 14 · 2021: 20 · 2020: 16 · 2019: 15 · 2018: 22 · 2017: 16 · 2016: 25 · 2015: 28 · 2014: 14 · 2013: 30 · 2012: 29
- FWCI
- 25.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- monocytes, macrophages, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, Salmonella typhimurium, Gram-positive pathogens, Gram-negative pathogens, inflammatory cytokines, MAPK signaling
- MeSH terms
- Animals, Anti-Infective Agents, Bacterial Infections, Disease Models, Animal, Gene Expression Regulation, Humans, Immunity, Innate, Inflammation, Lipopolysaccharides, Peptides, Treatment Outcome, Models, Immunological, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review